4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-16-061295
Senior VP - Drug Discovery sold 30,000 shares at $4.06 ($121,800)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-25 | Sale : show line 1 in the form | −30,000 | $4.06 | $121,800 | 111,428 | D |
| Open-market sales · 30,000 sh · avg $4.06 · $121,800 | ||||||
Loading xslF345X03/form4.xml…